Coinfection
Coverage of the 2017 AASLD Liver Meeting
- Details
- Category: HBV Treatment
- Published on Thursday, 30 November 2017 00:00
- Written by HIVandHepatitis.com
HIVandHepatitis.com coverage of the 2017 American Association for the Study of Liver Diseases (AASLD) Liver Meeting in Washington, DC, October 20-24, 2017.
Conference highlights include direct-acting antiviral therapy for difficult-to-treat people with hepatitis C, novel hepatitis B agents, complications of viral hepatitis, and NAFLD/NASH.
Full coverage listing by topic
11/30/17
Coverage of IDWeek 2017
- Details
- Category: HIV Treatment
- Published on Thursday, 30 November 2017 00:00
- Written by HIVandHepatitis.com
HIVandHepatitis.com coverage of IDWeek 2017, held October 4-8, 2017, in San Diego.
- Long-Acting Monoclonal Antibody Effective Against Multidrug-Resistant HIV
- Single-Tablet Protease Inhibitor Regimen Maintains Viral Suppression for a Year
11/30/17
IAS 2017: Hepatitis C treatment is Effective and Feasible in Africa
- Details
- Category: HCV Treatment
- Published on Friday, 28 July 2017 00:00
- Written by Liz Highleyman
Treatment for hepatitis C in sub-Saharan Africa can produce cure rates as high as those seen in industrialized countries, with high adherence and minimal side effects, according to a presentation this week at the 9th International AIDS Society Conference on HIV Science (IAS 2017) in Paris.
Coverage of the 16th European AIDS Conference
- Details
- Category: HIV Treatment
- Published on Tuesday, 14 November 2017 00:00
- Written by HIVandHepatitis.com
HIVandHepatitis.com and NAM coverage of the 16th European AIDS Conference (EACS 2017), October 25-27 2017, in Milan.
Coverage of the 2017 Harm Reduction International Conference
- Details
- Category: HIV Treatment
- Published on Wednesday, 31 May 2017 00:00
- Written by HIVandHepatitis.com
HIVand Hepatitis.com coverage of the 2017 Harm Reduction International Conference, May 14-17, 2017, in Montreal.
5/31/17
EACS 2017: Hepatitis C Halved among Spanish People with HIV Thanks to HCV Treatment
- Details
- Category: HIV/HCV Coinfection
- Published on Tuesday, 31 October 2017 00:00
- Written by Keith Alcorn
Spain is making dramatic progress towards eliminating hepatitis C among people living with HIV because of widespread use of direct-acting antivirals, Juan Berenguer of Hospital Gregorio Marañón in Madrid reported last week at the 16th European AIDS Conference (EACS 2017) in Milan.
Coverage of the 2017 Conference on Retroviruses and Opportunistic Infections
- Details
- Category: HIV Treatment
- Published on Sunday, 16 April 2017 00:00
- Written by HIVandHepatitis.com
HIVandHepatitis.com coverage of the 2017 Conference on Retroviruses and Opportunistic infections (CROI 2017), February 13-16, 2017, in Seattle.
Full coverage listing by topic
4/16/17
IAS 2017: Glecaprevir/ Pibrentasvir Effective for People with HIV/HCV Coinfection
- Details
- Category: HCV Treatment
- Published on Monday, 07 August 2017 00:00
- Written by Liz Highleyman
AbbVie's new 8-week pangenotypic regimen combining glecaprevir and pibrentasvir cured almost all HIV-positive people with hepatitis C coinfection in the EXPEDITION-2 study, according to a presentation at the 9th International AIDS Society Conference on HIV Science (IAS 2017) last month in Paris.
CROI 2017: Higher than Expected HCV Prevalence Among HIV- Gay Men in Amsterdam PrEP Program
- Details
- Category: HIV/HCV Coinfection
- Published on Wednesday, 22 March 2017 00:00
- Written by Liz Highleyman
An unexpectedly high number of HIV-negative gay and bisexual men taking pre-exposure prophylaxis (PrEP) in Amsterdam were found to have hepatitis C virus (HCV) infection, suggesting HCV is being transmitted sexually between men with and without HIV, according to a presentation last month at the Conference on Retroviruses and Opportunistic Infections in Seattle.
Web Design and Development by